| IV-01 Brigitte Lacroix A quantitative framework integrating exposure, efficacy, receptor occupancy and tolerability to propose evidence-based dose regimens for padsevonil Thursday 15:10-16:40 |
| IV-01 Brigitte Lacroix A quantitative framework integrating exposure, efficacy, receptor occupancy and tolerability to propose evidence-based dose regimens for padsevonil Thursday 15:10-16:40 |